| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-20 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-15 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.3 | 8e-09 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |